World Health Organization: The top 10 causes of death, 2020. Available at https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed April 30, 202110.1016/j.ekir.2019.12.003)| false
JagerKJ, KovesdyC, LanghamR, RosenbergM, JhaV, ZoccaliC: A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int96: 1048–1050, 201910.1016/j.kint.2019.07.012
JagerKJ, KovesdyC, LanghamR, RosenbergM, JhaV, ZoccaliC: A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96: 1048–1050, 201910.1016/j.kint.2019.07.01210.1038/ki.2013.153)| false
LewingtonAJ, CerdáJ, MehtaRL: Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int84: 457–467, 201310.1038/ki.2013.153PubMed
LewingtonAJ, CerdáJ, MehtaRL: Raising awareness of acute kidney injury: A global perspective of a silent killer. Kidney Int 84: 457–467, 201310.1038/ki.2013.153PubMed10.1159/000489897)| false
International Society of Nephrology: Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-Stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions, Brussels, Belgium, International Society of Nephrology, 2019
International Society of Nephrology: Global Kidney Health Atlas: A Report by the International Society of Nephrology on the Global Burden of End-Stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions, Brussels, Belgium, International Society of Nephrology, 201910.1016/S0140-6736(20)30045-3)| false
BikbovB, PericoN, RemuzziG; on behalf of the GBD Genitourinary Diseases Expert Group: Disparities in chronic kidney disease prevalence among males and females in 195 countries: Analysis of the Global Burden of Disease 2016 Study. Nephron139: 313–318, 201810.1159/000489897PubMed
BikbovB, PericoN, RemuzziG; on behalf of the GBD Genitourinary Diseases Expert Group: Disparities in chronic kidney disease prevalence among males and females in 195 countries: Analysis of the Global Burden of Disease 2016 Study. Nephron 139: 313–318, 201810.1159/000489897PubMed)| false
GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet395: 709–733, 202010.1016/s0140-6736(20)30045-3PubMed
GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709–733, 202010.1016/s0140-6736(20)30045-3PubMed)| false
International Society of Nephrology: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Available at https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed April 30, 2021)| false
International Society of Nephrology: Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Available at https://www2.theisn.org/GKHA. Accessed April 30, 2021
International Society of Nephrology: Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Available at https://www2.theisn.org/GKHA. Accessed April 30, 202110.1016/S0140-6736(14)61601-9)| false
GBD 2019 Risk Factor Collaborators: The Lancet: Latest global disease estimates reveal perfect storm of rising chronic diseases and public health failures fuelling COVID-19 pandemic, 2021. Available at: http://www.healthdata.org/news-release/lancet-latest-global-disease-estimates-reveal-perfect-storm-rising-chronic-diseases-and. Accessed April 30, 202110.1136/bmjopen-2020-047245)| false
YeungE, BelloAK, LevinA, LunneyM, OsmanMA, YeF, et al.: Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey. BMJ Open11: e047245, 202110.1136/bmjopen-2020-047245PubMed
YeungE, BelloAK, LevinA, LunneyM, OsmanMA, YeF, : Current status of health systems financing and oversight for end-stage kidney disease care: A cross-sectional global survey. BMJ Open 11: e047245, 202110.1136/bmjopen-2020-047245PubMed)| false
BelloAK, LevinA, LunneyM, OsmanMA, YeF, AshuntantangGE, et al.: Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ367: l5873, 201910.1136/bmj.l5873PubMed
BelloAK, LevinA, LunneyM, OsmanMA, YeF, AshuntantangGE, : Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ 367: l5873, 201910.1136/bmj.l5873PubMed10.1016/S0140-6736(18)32203-7)| false
LuyckxVA: Ethical Challenges Relating to Provision of Sustainable Renal Care in Resource Limited Settings–Focus on Sub-Saharan Africa PhD thesis, University of Zurich, 2019.
LuyckxVA: Ethical Challenges Relating to Provision of Sustainable Renal Care in Resource Limited Settings–Focus on Sub-Saharan Africa PhD thesis, University of Zurich, 2019.10.1038/ki.2014.369)| false
GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet392: 1736–1788, 201810.1016/s0140-6736(18)32203-7PubMed
GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: 1736–1788, 201810.1016/s0140-6736(18)32203-7PubMed10.2471/BLT.17.206441)| false
Garcia-GarciaG, JhaV; World Kidney Day Steering Committee: CKD in disadvantaged populations. Kidney Int 87: 251–253, 201510.1038/ki.2014.369PubMed10.1136/medethics-2017-104321)| false
LuyckxVA, TonelliM, StaniferJW: The global burden of kidney disease and the sustainable development goals. Bull World Health Organ96: 414–422D, 201810.2471/BLT.17.206441PubMed
LuyckxVA, TonelliM, StaniferJW: The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96: 414–422D, 201810.2471/BLT.17.206441PubMed10.1038/s41581-020-00363-6)| false
LuyckxVA, Al-AlyZ, BelloAK, Bellorin-FontE, CarliniRG, FabianJ, et al.: Sustainable Development Goals relevant to kidney health: An update on progress. Nat Rev Nephrol17: 15–32, 202110.1038/s41581-020-00363-6PubMed
LuyckxVA, Al-AlyZ, BelloAK, Bellorin-FontE, CarliniRG, FabianJ, : Sustainable Development Goals relevant to kidney health: An update on progress. Nat Rev Nephrol 17: 15–32, 202110.1038/s41581-020-00363-6PubMed)| false
NishtarS, NiinistöS, SirisenaM, VázquezT, SkvortsovaV, RubinsteinA, et al.; Commissioners of the WHO Independent High-Level Commission on NCDs: Time to deliver: Report of the WHO Independent High-Level Commission on NCDs. Lancet392: 245–252, 201810.1016/S0140-6736(18)31258-3PubMed
NishtarS, NiinistöS, SirisenaM, VázquezT, SkvortsovaV, RubinsteinA, ; Commissioners of the WHO Independent High-Level Commission on NCDs: Time to deliver: Report of the WHO Independent High-Level Commission on NCDs. Lancet 392: 245–252, 201810.1016/S0140-6736(18)31258-3PubMed)| false
World Health Organization: Global Action Plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://www.who.int/nmh/events/ncd_action_plan/en/. Accessed April 30, 2021
World Health Organization: Global Action Plan for the prevention and control of noncommunicable diseases 2013-2020. Available at: http://www.who.int/nmh/events/ncd_action_plan/en/. Accessed April 30, 202110.34067/KID.0006932020)| false
HarperT, GhebreyesusTA, ForeH, UlsteinD-I: Building back better: Investing in healthy populations and resilient health systems for NCDs and mental health to be better prepared for future crises, 2021. Available at: https://foresightglobalhealth.com/investing-in-healthy-populations-and-resilient-health-systems-for-ncds-and-mental-health-to-be-better-prepared-for-future-crises/. Accessed April 30, 202110.1016/S0140-6736(18)31694-5)| false
LuyckxVA: Equity is key to build back better after COVID-19: Prioritize noncommunicable diseases and kidney health. Kidney3602: 747–750, 202110.34067/KID.0006932020PubMed
LuyckxVA: Equity is key to build back better after COVID-19: Prioritize noncommunicable diseases and kidney health. Kidney360 2: 747–750, 202110.34067/KID.0006932020PubMed)| false
ForemanKJ, MarquezN, DolgertA, FukutakiK, FullmanN, McGaugheyM, et al.: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet392: 2052–2090, 201810.1016/s0140-6736(18)31694-5PubMed
ForemanKJ, MarquezN, DolgertA, FukutakiK, FullmanN, McGaugheyM, : Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392: 2052–2090, 201810.1016/s0140-6736(18)31694-5PubMed)| false
United Nations: Sustainable Development Goals, 2020. Available at: https://www.un.org/sustainabledevelopment/. Accessed April 30, 202110.1136/bmjgh-2017-000639)| false
World Health Organization: Saving lives, spending less: A strategic response to noncommunicable diseases, 2018. Available at: https://www.who.int/ncds/management/ncds-strategic-response/en/. Accessed April 30, 202110.1001/jamanetworkopen.2019.10704)| false
ThomasLM, D’AmbruosoL, BalabanovaD: Verbal autopsy in health policy and systems: A literature review. BMJ Glob Health3: e000639, 201810.1136/bmjgh-2017-000639PubMed
ThomasLM, D’AmbruosoL, BalabanovaD: Verbal autopsy in health policy and systems: A literature review. BMJ Glob Health 3: e000639, 201810.1136/bmjgh-2017-000639PubMed10.1681/ASN.2020030277)| false
TonelliM, DickinsonJA: Early detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol31: 1931–1940, 202010.1681/ASN.2020030277PubMed
TonelliM, DickinsonJA: Early detection of CKD: Implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol 31: 1931–1940, 202010.1681/ASN.2020030277PubMed10.1186/s12992-021-00676-6)| false
HtayH, AlrukhaimiM, AshuntantangGE, BelloAK, Bellorin-FontE, Benghanem GharbiM, et al.: Global access of patients with kidney disease to health technologies and medications: Findings from the Global Kidney Health Atlas project. Kidney Int Suppl (2011)8: 64–73, 201810.1016/j.kisu.2017.10.010
HtayH, AlrukhaimiM, AshuntantangGE, BelloAK, Bellorin-FontE, Benghanem GharbiM, : Global access of patients with kidney disease to health technologies and medications: Findings from the Global Kidney Health Atlas project. Kidney Int Suppl (2011) 8: 64–73, 201810.1016/j.kisu.2017.10.01010.1136/bmjgh-2018-001033)| false
Bernabé-OrtizA, Zafra-TanakaJH, Moscoso-PorrasM, SampathR, VetterB, MirandaJJ, et al.: Diagnostics and monitoring tools for noncommunicable diseases: A missing component in the global response. Global Health17: 26, 202110.1186/s12992-021-00676-6PubMed
Bernabé-OrtizA, Zafra-TanakaJH, Moscoso-PorrasM, SampathR, VetterB, MirandaJJ, : Diagnostics and monitoring tools for noncommunicable diseases: A missing component in the global response. Global Health 17: 26, 202110.1186/s12992-021-00676-6PubMed10.1016/S0140-6736(17)30788-2)| false
Velazquez BerumenA, GarnerS, HillSR, SwaminathanS: Making diagnostic tests as essential as medicines. BMJ Glob Health3: e001033, 201810.1136/bmjgh-2018-001033PubMed
Velazquez BerumenA, GarnerS, HillSR, SwaminathanS: Making diagnostic tests as essential as medicines. BMJ Glob Health 3: e001033, 201810.1136/bmjgh-2018-001033PubMed)| false
LevinA, TonelliM, BonventreJ, CoreshJ, DonnerJA, FogoAB, et al.; ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet390: 1888–1917, 201710.1016/S0140-6736(17)30788-2PubMed
LevinA, TonelliM, BonventreJ, CoreshJ, DonnerJA, FogoAB, ; ISN Global Kidney Health Summit participants: Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet 390: 1888–1917, 201710.1016/S0140-6736(17)30788-2PubMed10.1038/nrneph.2017.63)| false
World Health Organization: HEARTS Technical Package, 2018. Available at: http://www.who.int/cardiovascular_diseases/hearts/en/. Accessed May 5, 202110.1016/j.kisu.2017.07.003)| false
VanholderR, AnnemansL, BrownE, GansevoortR, Gout-ZwartJJ, LameireN, et al.; European Kidney Health Alliance: Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol13: 393–409, 201710.1038/nrneph.2017.63PubMed
VanholderR, AnnemansL, BrownE, GansevoortR, Gout-ZwartJJ, LameireN, ; European Kidney Health Alliance: Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13: 393–409, 201710.1038/nrneph.2017.63PubMed10.1016/S0140-6736(16)31599-9)| false
WirtzVJ, HogerzeilHV, GrayAL, BigdeliM, de JoncheereCP, EwenMA, et al.: Essential medicines for universal health coverage. Lancet389: 403–476, 201710.1016/S0140-6736(16)31599-9PubMed
ChowCK, NguyenTN, MarschnerS, DiazR, RahmanO, AvezumA, et al.; PURE Study: Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health5: e002640, 202010.1136/bmjgh-2020-002640PubMed
ChowCK, NguyenTN, MarschnerS, DiazR, RahmanO, AvezumA, ; PURE Study: Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries. BMJ Glob Health 5: e002640, 202010.1136/bmjgh-2020-002640PubMed10.1016/S0140-6736(18)30323-4)| false
KhatibR, McKeeM, ShannonH, ChowC, RangarajanS, TeoK, et al.; PURE study investigators: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet387: 61–69, 201610.1016/S0140-6736(15)00469-9PubMed
KhatibR, McKeeM, ShannonH, ChowC, RangarajanS, TeoK, ; PURE study investigators: Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet 387: 61–69, 201610.1016/S0140-6736(15)00469-9PubMed)| false
EssueBM, et al.: Disease Control Priorities. Improving Health and Reducing Poverty, edited by JamisonDT, et al., Vol. 9, Washington, DC, World Bank, 2018, pp 121–143
EssueBM, : Disease Control Priorities. Improving Health and Reducing Poverty, edited by JamisonDT, et al., Vol. 9, Washington, DC, World Bank, 2018, pp 121–14310.1016/S0140-6736(18)31668-4)| false
EssueBM, WongG, ChapmanJ, LiQ, JanS: How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrol14: 5, 201310.1186/1471-2369-14-5PubMed
EssueBM, WongG, ChapmanJ, LiQ, JanS: How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephrol 14: 5, 201310.1186/1471-2369-14-5PubMed10.1016/S2214-109X(18)30386-3)| false
KrukME, GageAD, JosephNT, DanaeiG, García-SaisóS, SalomonJA: Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet392: 2203–2212, 201810.1016/s0140-6736(18)31668-4PubMed
KrukME, GageAD, JosephNT, DanaeiG, García-SaisóS, SalomonJA: Mortality due to low-quality health systems in the universal health coverage era: A systematic analysis of amenable deaths in 137 countries. Lancet 392: 2203–2212, 201810.1016/s0140-6736(18)31668-4PubMed10.1093/ckj/sfab070)| false
KrukME, GageAD, ArsenaultC, JordanK, LeslieHH, Roder-DeWanS, et al.: High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob Health6: e1196–e1252, 201810.1016/S2214-109X(18)30386-3PubMed
KrukME, GageAD, ArsenaultC, JordanK, LeslieHH, Roder-DeWanS, : High-quality health systems in the Sustainable Development Goals era: Time for a revolution. Lancet Glob Health 6: e1196–e1252, 201810.1016/S2214-109X(18)30386-3PubMed10.1038/s41581-020-00389-w)| false
VanholderR, AnnemansL, BelloAK, BikbovB, GallegoD, GansevoortRT, et al.: Fighting the unbearable lightness of neglecting kidney health: The decade of the kidney. Clin Kidney J14: 1719–1730, 202110.1093/ckj/sfab070PubMed
BignallONR2nd, CrewsDC: Stony the road we trod: Towards racial justice in kidney care. Nat Rev Nephrol 17: 79–80, 202110.1038/s41581-020-00389-wPubMed10.1093/ndt/gfaa314)| false
Kevin TuckerJ: Social justice as a tool to eliminate inequities in kidney disease. Semin Nephrol 41: 203–210, 202110.1016/j.semnephrol.2021.05.001PubMed)| false
ERA-EDTA Council; ERACODA Working Group: Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant36: 87–94, 202110.1093/ndt/gfaa314PubMed
ERA-EDTA Council; ERACODA Working Group: Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA. Nephrol Dial Transplant 36: 87–94, 202110.1093/ndt/gfaa314PubMed)| false
